The Valley Desk

Clinical trial reportJournal of immunology (Baltimore, Md. : 1950)Published

Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapy

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of immunology (Baltimore, Md. : 1950)
Published
Subject terms
Humans; Neoplasm Metastasis; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; Immunotherapy; Adult; Aged; Middle Aged; Female; Antibodies, Monoclonal, Humanized; Triple Negative Breast Neoplasms; Immune Checkpoint Inhibitors
PubMed ID
40338159
Added to directory
Source checked

Report a correction or request removal